Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge

[1]  K. Stavem,et al.  Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study , 2020, Thorax.

[2]  J. Chee,et al.  Understanding COVID-19-Related Olfactory Dysfunction. , 2020, JAMA otolaryngology-- head & neck surgery.

[3]  A. Helenius,et al.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.

[4]  A. Altundağ,et al.  Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia , 2020, Academic Radiology.

[5]  H. Randeva,et al.  Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19 , 2020, Molecular medicine reports.

[6]  C. Eloit,et al.  Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts. , 2020, Neurology.

[7]  A. Eshraghi,et al.  Olfactory and gustatory dysfunction in COVID‐19 patients: A meta‐analysis study , 2020, Physiological reports.

[8]  C. V. von Bartheld,et al.  Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences. , 2020, ACS chemical neuroscience.

[9]  J. Klussmann,et al.  Olfactory dysfunction in patients after recovering from COVID-19 , 2020, Acta oto-laryngologica.

[10]  M. Gross,et al.  Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19 , 2020, Medical Hypotheses.

[11]  Murugappan Ramanathan,et al.  Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication , 2020, European Respiratory Journal.

[12]  F. Biglioli,et al.  Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study , 2020, The Journal of Laryngology & Otology.

[13]  H. Bibi,et al.  Age-Dependent Sensory Impairment in COVID-19 Infection and its Correlation with ACE2 Expression , 2020, The Pediatric infectious disease journal.

[14]  J. Luers,et al.  Persisting olfactory dysfunction in patients after recovering from COVID-19 , 2020, Journal of Infection.

[15]  I. Alobid,et al.  Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients , 2020, European Archives of Oto-Rhino-Laryngology.

[16]  R. Schlosser,et al.  Treatment of post‐viral olfactory dysfunction: an evidence‐based review with recommendations , 2020, International forum of allergy & rhinology.

[17]  C. V. von Bartheld,et al.  Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences , 2020, medRxiv.

[18]  I. Lopez,et al.  Anosmia in COVID-19: Mechanisms and Significance , 2020, Chemical senses.

[19]  A. Aliaghaei,et al.  Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia , 2020, ACS chemical neuroscience.

[20]  S. Ferreira,et al.  Olfactory and taste disorders in COVID-19: a systematic review , 2020, Brazilian Journal of Otorhinolaryngology.

[21]  D. Matthews,et al.  Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.

[22]  L. Vaira,et al.  Clinical and Radiological Evaluations of COVID‐19 Patients With Anosmia: Preliminary Report , 2020, medRxiv.

[23]  M. A. Fornazieri,et al.  Incomplete and late recovery of sudden olfactory dysfunction in COVID-19 , 2020, Brazilian Journal of Otorhinolaryngology.

[24]  C. V. von Bartheld,et al.  Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age , 2020, ACS chemical neuroscience.

[25]  Richard L. Doty,et al.  Smell dysfunction: a biomarker for COVID‐19 , 2020, International forum of allergy & rhinology.

[26]  Z. Patel,et al.  A primer on viral‐associated olfactory loss in the era of COVID‐19 , 2020, International forum of allergy & rhinology.

[27]  Russell B. Fletcher,et al.  Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia , 2020, Science Advances.

[28]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[29]  F. Fischmeister,et al.  Olfactory training induces changes in regional functional connectivity in patients with long-term smell loss , 2015, NeuroImage: Clinical.

[30]  T. Hummel,et al.  Modified olfactory training in patients with postinfectious olfactory loss , 2015, The Laryngoscope.

[31]  T. Hummel,et al.  Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study , 2014, The Laryngoscope.

[32]  R. Reed,et al.  A Genetic Model of Chronic Rhinosinusitis-Associated Olfactory Inflammation Reveals Reversible Functional Impairment and Dramatic Neuroepithelial Reorganization , 2010, The Journal of Neuroscience.

[33]  T. Hummel,et al.  Effects of olfactory training in patients with olfactory loss , 2009, The Laryngoscope.

[34]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[35]  T. Kitsukawa,et al.  Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. , 1996, Journal of neurobiology.